Vuong Trieu - 22 Nov 2022 Form 4 Insider Report for Oncotelic Therapeutics, Inc. (OTLC)

Role
CHAIRMAN AND CEO, Director, 10%+ Owner
Signature
/s/ Trieu, Vuong
Issuer symbol
OTLC
Transactions as of
22 Nov 2022
Net transactions value
+$5,600
Form type
4
Filing time
25 Nov 2022, 08:00:38 UTC
Previous filing
28 Sep 2022
Next filing
07 Dec 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OTLC Common Stock Purchase $5,600 +70,000 +0.08% $0.0800 90,438,021 22 Nov 2022 Direct
holding OTLC Common Stock 16,780,384 22 Nov 2022 By Autotelic, Inc.
holding OTLC Common Stock 6,872,529 22 Nov 2022 By Spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

Dr. Trieu purchased 70,000 shares of Oncotelic Therapeutics, Inc. in his individual capacity on November 22, 2022 from the open market at a price of $0.08.